![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gross Volker
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1257-1265
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide beneficial in collagenous colitis
Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :